• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications

    PRESS RELEASE

    Milvexian Granted U.S. FDA Fast Track Designation in Phase 3 Librexia Program

    BUSINESSWIRE

    BMS, J&J kick off pivotal studies of FXIa inhibitor milvexian

    PRESS RELEASE

    The BMS-Janssen Collaboration Launches PIII Trial Evaluating Milvexian

    BUSINESSWIRE

    Results From PII Study of Milvexian Show Favorable Antithrombotic Profile

    BUSINESSWIRE

    New J&J CEO Duato points out 5 promising pipeline meds

    FIERCEPHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.